Biochips Market By Product (DNA Chip, Protein Chip, Lab-on-a-chip, and Others), By Application (Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture, and Others), By End-User (Biotechnology & Pharmaceutical Companies, Hospitals & Diagnostics Centers, Academic & Research Institutes, and Others), and By Region - Trends, Analysis and Forecast till 2034

Biochips market is expected to grow at a 14.8% CAGR to reach US$ 41.8 billion by 2034, from its estimated value of US$ 10.5 billion in 2024.

A biochip is a comprehensive basic functional unit that can carry out numerous biochemical operations at once. The biochip is a microscale laboratory featuring a microarray mounted on a solid substrate. It can carry out multiple biochemical operations, enabling increased speed and volume throughput. Biochips' versatile applications are regarded as a key development in medical technology. Proteomics, genomics, molecular diagnostics, and drug discovery and development are among the fields of study that heavily utilize biochips.